Recruiting

Understanding vulnerability factors in older adults with serious illnesses

Plain-English translation of NCT07740239 on ClinicalTrials.gov ↗ · Source last updated July 2026 · Translation generated August 2026 · How we translate trials

What is this trial?

This is a research study following about 1,500 older adults (age 60 and up) who have been diagnosed with serious medical conditions, including certain cancers, pelvic fractures, brain bleeding, or brain tumors. Researchers want to understand what factors make some patients more vulnerable when facing these serious illnesses, and how these vulnerability factors affect treatment choices, survival time, and quality of life.

Doctors know that some older patients with serious illnesses become very fragile and may not be able to handle aggressive treatments. This study exists to identify which patients are at highest risk of becoming vulnerable, so doctors can better plan personalized care and help patients make informed decisions about their treatment earlier.

Do you qualify?

You likely qualify if…

you are 60 years old or older (or 18+ if you are receiving high-dose chemotherapy with stem cell transplant)
you have been diagnosed with or are suspected to have one of the studied conditions: prostate cancer, lung cancer, pelvic fracture, chronic subdural hematoma (brain bleeding), or brain metastasis
you have had recent imaging scans (within the last 45 days before joining)
you are willing and able to give written consent to participate
study procedures are completed within a specific timeframe based on your condition and treatment start date

You likely don't qualify if…

you are unable or unwilling to give written consent to join the study
the research doctor decides you are not medically suitable for the study
you do not meet the required timing for completing study procedures relative to your diagnosis or treatment start

What participation looks like

If you join, you will complete assessments and answer questions about your health, well-being, and medical history at one of three university hospitals in Finland (Tampere, Kuopio, or Oulu). Your medical records and recent imaging will also be reviewed. The study does not involve taking a new medication or undergoing a new procedure — instead, researchers will follow your existing care and treatment path while collecting information about how you are doing.

AI-generated summary from trial data · Aug 5, 2026 · Not medical advice

Trial locations(1 site)

Finland

Tampere University Hospital, Tampere